Taiwanese researchers find breakthrough in stem cell study

The iPS can, as proven in preliminary experiments, be turned into cells of the nerves, skin, liver, pancreas and other organs. By doing so, the cells may in the future, become key to treating diseases.

Research Associate Yen Ling-yu pointed out the difficulty in obtaining stem cells, describing the process as riddled with ethical concerns. Scientists in the U.S. and Japan have been figuring out ways to make ordinary cells useful in stem cell technology for years.

The process by which ordinary cells become stem cells requires four additional transcription factors (OCT4, SOX2, c-MYC and KLF4). Research shows that the c-MYC and KLF4 genes could turn cells cancerous, which has greatly limited its scope of application for scientists.

The human umbilical vein endothelial cells (HUVECs) used by National Health Research Institute scientists were found to be rich in KLF4 gene, a key role in stem cell transformation. The umbilical cells did not require the cancer-inducing genes of c-MYC and KLF4 to turn into a stem cell, scientists discovered.

The researchers pointed out that the HUVECs were taken from the umbilical cords of newborn infants, which are often discarded by obstetricians anyway. In the future, the new stem cells can help treat strokes, diabetes and other diseases. The “all-purpose” factor of the cell — its ability to be turned into other types of cells in the body — opens up new opportunities for it to be tested as a treatment of disease.

Subscribe to The China Post and save 25%. Click here

SharePrintEmail

Write a Comment

Terms

Enter your comments - 3000 characters max

Type in image code

Submit

 Receive China Post promos
 Respond to this email